Sarah Yim, MD

Article

OA drug development needs patient-focused approach to biomarkers and outcome measures

Author:: Sarah Yim, MD

Publish date: December 13, 2016

Renewed interest in establishing more ways for potential osteoarthritis drug candidates to be evaluated in clinical trials has led to calls for new...